The beneficial role of photobiomodulation in neurodegenerative diseases
A Abijo, CY Lee, CY Huang, PC Ho, KJ Tsai - Biomedicines, 2023 - mdpi.com
Photobiomodulation (PBM), also known as Low-level Laser Therapy (LLLT), involves the
use of light from a laser or light-emitting diode (LED) in the treatment of various disorders …
use of light from a laser or light-emitting diode (LED) in the treatment of various disorders …
The effect of photobiomodulation on the brain during wakefulness and sleep
C Moro, A Valverde, M Dole, J Hoh Kam… - Frontiers in …, 2022 - frontiersin.org
Over the last seventy years or so, many previous studies have shown that
photobiomodulation, the use of red to near infrared light on body tissues, can improve …
photobiomodulation, the use of red to near infrared light on body tissues, can improve …
Near-infrared light reduces β-amyloid-stimulated microglial toxicity and enhances survival of neurons: Mechanisms of light therapy for Alzheimer's disease
YV Stepanov, I Golovynska, R Zhang… - Alzheimer's research & …, 2022 - Springer
Background Low-intensity light can decelerate neurodegenerative disease progression and
reduce amyloid β (Aβ) levels in the cortex, though the cellular and molecular mechanisms by …
reduce amyloid β (Aβ) levels in the cortex, though the cellular and molecular mechanisms by …
Photobiomodulation improves the synapses and cognitive function and ameliorates epileptic seizure by inhibiting downregulation of Nlgn3
Background Temporal lobe epilepsy (TLE) remains one of the most drug-resistant focal
epilepsies. Glutamate excitotoxicity and neuroinflammation which leads to loss of synaptic …
epilepsies. Glutamate excitotoxicity and neuroinflammation which leads to loss of synaptic …
[HTML][HTML] Photobiomodulation in Alzheimer's disease—A complementary method to state-of-the-art pharmaceutical formulations and nanomedicine?
Alzheimer's disease (AD), as a neurodegenerative disorder, usually develops slowly but
gradually worsens. It accounts for approximately 70% of dementia cases worldwide, and is …
gradually worsens. It accounts for approximately 70% of dementia cases worldwide, and is …
Electromagnetic radiation and biophoton emission in neuronal communication and neurodegenerative diseases
A Erboz, E Kesekler, PL Gentili, VN Uversky… - Progress in Biophysics …, 2024 - Elsevier
The intersection of electromagnetic radiation and neuronal communication, focusing on the
potential role of biophoton emission in brain function and neurodegenerative diseases is an …
potential role of biophoton emission in brain function and neurodegenerative diseases is an …
Transcranial photobiomodulation improves insulin therapy in diabetic microglial reactivity and the brain drainage system
S Liu, D Li, T Yu, J Zhu… - Communications …, 2023 - nature.com
The dysfunction of microglia in the development of diabetes is associated with various
diabetic complications, while traditional insulin therapy is insufficient to rapidly restore the …
diabetic complications, while traditional insulin therapy is insufficient to rapidly restore the …
Rationale for 1068 nm photobiomodulation therapy (PBMT) as a novel, non-invasive treatment for COVID-19 and other coronaviruses: roles of NO and hsp70
LC Kitchen, M Berman, J Halper, P Chazot - International Journal of …, 2022 - mdpi.com
Researchers from across the world are seeking to develop effective treatments for the
ongoing coronavirus disease 2019 (COVID-19) outbreak, which arose as a major public …
ongoing coronavirus disease 2019 (COVID-19) outbreak, which arose as a major public …
Extracellular vesicles from hiPSC-NSCs can prevent peripheral inflammation-induced cognitive dysfunction with inflammasome inhibition and improved neurogenesis …
Extracellular vesicles (EVs) released by human induced pluripotent stem cell-derived neural
stem cells (hiPSC-NSCs) are enriched with miRNAs and proteins capable of mediating …
stem cells (hiPSC-NSCs) are enriched with miRNAs and proteins capable of mediating …
[HTML][HTML] Repetitive transcranial magnetic stimulation for improving cognitive function in patients with mild cognitive impairment: a systematic review
L Jiang, H Cui, C Zhang, X Cao, N Gu, Y Zhu… - Frontiers in aging …, 2021 - frontiersin.org
Background: Mild cognitive impairment (MCI) is an early stage of Alzheimer's disease.
Repetitive transcranial magnetic stimulation (rTMS) has been widely used in research into …
Repetitive transcranial magnetic stimulation (rTMS) has been widely used in research into …